{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T00:32:05Z","timestamp":1794443525405,"version":"4.9.1"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,5,16]],"date-time":"2024-05-16T00:00:00Z","timestamp":1715817600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,5,16]],"date-time":"2024-05-16T00:00:00Z","timestamp":1715817600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Clin Psychol Med Settings"],"published-print":{"date-parts":[[2025,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Pregnant women with opioid use disorder show elevated rates of comorbid mental health problems, both of which are associated with negative health outcomes for mothers and children. There is substantial evidence supporting the benefits of treatment of perinatal opioid use disorder, as well as perinatal depression and anxiety, but there are gaps in knowledge about the effectiveness of perinatal behavioral health interventions in the context of co-occurring substance use disorder. The current study seeks to address this gap by examining outcomes of a behavioral activation treatment in a group of peripartum women with opioid use disorder (<jats:italic>N<\/jats:italic>\u2009=\u200968). Behavioral activation has shown promise in treating co-occurring depression and substance use problems. The intervention was delivered as part of an integrated care treatment model, in which patients received co-located obstetric, substance use, and mental health care in a hospital-based clinic. Hierarchical linear modeling was used to assess change in symptoms over time. Results suggest that the group behavioral activation intervention was associated with reduced depression and anxiety symptoms, demonstrated by significant reductions in PHQ-9 and GAD-7 scores over the course of treatment. Moreover, there were indications that increased attendance was associated with further reductions in depressive symptoms. Results contribute to understanding the effectiveness of behavioral activation in the context of peripartum opioid use disorder. Findings also add to the evidence supporting integrated care models and offer a potential blueprint for improving outcomes and reducing barriers to care in this population.<\/jats:p>","DOI":"10.1007\/s10880-023-09984-y","type":"journal-article","created":{"date-parts":[[2024,5,16]],"date-time":"2024-05-16T09:05:17Z","timestamp":1715850317000},"page":"19-26","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Effectiveness of a Behavioral Activation Intervention for Peripartum Women with Opioid Use Disorder"],"prefix":"10.1007","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1442-2461","authenticated-orcid":false,"given":"Michael R.","family":"Vilensky","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole A.","family":"Arrato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristen M.","family":"Carpenter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,5,16]]},"reference":[{"key":"9984_CR1","unstructured":"American College of Obstetricians and Gynecologists (2017). Opioid use and opioid use disorder during pregnancy. Committee Opinion 711."},{"key":"9984_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s40429-017-0132-4","volume":"4","author":"CL Arnaudo","year":"2017","unstructured":"Arnaudo, C. L., Andraka-Christou, B., & Allgood, K. (2017). Psychiatric co-morbidities in pregnant women with opioid use disorders: Prevalence, impact, and implications for treatment. Current Addiction Reports, 4, 1\u201313.","journal-title":"Current Addiction Reports"},{"key":"9984_CR3","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.jad.2015.12.005","volume":"192","author":"A Bauer","year":"2016","unstructured":"Bauer, A., Knapp, M., & Parsonage, M. (2016). Lifetime costs of perinatal anxiety and depression. Journal of Affective Disorders, 192, 83\u201390.","journal-title":"Journal of Affective Disorders"},{"key":"9984_CR4","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1089\/jwh.2020.8875","volume":"30","author":"J Campbell","year":"2021","unstructured":"Campbell, J., Matoff-Stepp, S., Velez, M. L., Cox, H. H., & Laughon, K. (2021). Pregnancy-associated deaths from homicide, suicide, and drug overdose: Review of research and the intersection with intimate partner violence. Journal of Women\u2019s Health, 30, 236\u2013244.","journal-title":"Journal of Women's Health"},{"key":"9984_CR5","doi-asserted-by":"publisher","first-page":"2079","DOI":"10.1111\/add.15054","volume":"115","author":"LM Cleveland","year":"2020","unstructured":"Cleveland, L. M., McGlothen-Bell, K., Scott, L. A., & Recto, P. (2020). A life-course theory exploration of opioid-related maternal mortality in the United States. Addiction (abingdon, England), 115, 2079\u20132088.","journal-title":"Addiction (abingdon, England)"},{"issue":"3","key":"9984_CR6","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1111\/add.14049","volume":"113","author":"SB Daughters","year":"2018","unstructured":"Daughters, S. B., Magidson, J. F., Anand, D., Seitz-Brown, C. J., Chen, Y., & Baker, S. (2018). The effect of a behavioral activation treatment for substance use on post-treatment abstinence: A randomized controlled trial. Addiction (abingdon, England), 113(3), 535\u2013544.","journal-title":"Addiction (abingdon, England)"},{"key":"9984_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1146\/annurev-clinpsy-032210-104535","volume":"7","author":"S Dimidjian","year":"2011","unstructured":"Dimidjian, S., Barrera, M., Jr., Martell, C., Mu\u00f1oz, R. F., & Lewinsohn, P. M. (2011). The origins and current status of behavioral activation treatments for depression. Annual Review of Clinical Psychology, 7, 1\u201338.","journal-title":"Annual Review of Clinical Psychology"},{"key":"9984_CR8","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1037\/ccp0000151","volume":"85","author":"S Dimidjian","year":"2017","unstructured":"Dimidjian, S., Goodman, S. H., Sherwood, N. E., Simon, G. E., Ludman, E., Gallop, R., Welch, S. S., Boggs, J. M., Metcalf, C. A., Hubley, S., Powers, J. D., & Beck, A. (2017). A pragmatic randomized clinical trial of behavioral activation for depressed pregnant women. Journal of Consulting and Clinical Psychology, 85, 26\u201336.","journal-title":"Journal of Consulting and Clinical Psychology"},{"key":"9984_CR10","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1097\/ADM.0000000000000193","volume":"10","author":"K Dugosh","year":"2016","unstructured":"Dugosh, K., Abraham, A., Seymour, B., McLoyd, K., Chalk, M., & Festinger, D. (2016). A systematic review on the use of psychosocial interventions in conjunction with medications for the treatment of opioid addiction. Journal of Addiction Medicine, 10, 93\u2013103.","journal-title":"Journal of Addiction Medicine"},{"key":"9984_CR11","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/j.ajog.2019.05.045","volume":"221","author":"S Goldman-Mellor","year":"2019","unstructured":"Goldman-Mellor, S., & Margerison, C. E. (2019). Maternal drug-related death and suicide are leading causes of postpartum death in California. American Journal of Obstetrics and Gynecology, 221, 489.","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"9984_CR12","volume-title":"Behavioral activation for perinatal depression: A workbook for clinicians","author":"JK Gollan","year":"2015","unstructured":"Gollan, J. K., & Juskiewicz, K. (2015). Behavioral activation for perinatal depression: A workbook for clinicians. Chicago: Northwestern University Feinberg School of Medicine."},{"key":"9984_CR13","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1111\/j.1523-536X.2008.00296.x","volume":"36","author":"JH Goodman","year":"2009","unstructured":"Goodman, J. H. (2009). Women\u2019s attitudes, preferences, and perceived barriers to treatment for perinatal depression. Birth, 36, 60\u201369.","journal-title":"Birth"},{"key":"9984_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajogmf.2021.100489","volume":"4","author":"DJ Goodman","year":"2022","unstructured":"Goodman, D. J., Saunders, E. C., Frew, J. R., Arsan, C., Xie, H., Bonasia, K. L., Flanagan, V. A., Lord, S. E., & Brunette, M. F. (2022). Integrated vs nonintegrated treatment for perinatal opioid use disorder: Retrospective cohort study. American Journal of Obstetrics & Gynecology MFM, 4, 100489.","journal-title":"American Journal of Obstetrics & Gynecology MFM"},{"key":"9984_CR16","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1146\/annurev.psych.55.090902.142033","volume":"55","author":"ST Higgins","year":"2004","unstructured":"Higgins, S. T., Heil, S. H., & Lussier, J. P. (2004). Clinical implications of reinforcement as a determinant of substance use disorders. Annual Review of Psychology, 55, 431\u2013461.","journal-title":"Annual Review of Psychology"},{"key":"9984_CR17","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1001\/jama.2020.24991","volume":"325","author":"AH Hirai","year":"2021","unstructured":"Hirai, A. H., Ko, J. Y., Owens, P. L., Stocks, C., & Patrick, S. W. (2021). Neonatal abstinence syndrome and maternal opioid-related diagnoses in the US, 2010\u20132017. JAMA, 325, 146\u2013155.","journal-title":"JAMA"},{"key":"9984_CR18","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1016\/S0140-6736(14)62040-7","volume":"384","author":"LM Howard","year":"2014","unstructured":"Howard, L. M., Piot, P., & Stein, A. (2014). No health without perinatal mental health. Lancet (london, England), 384, 1723\u20131724.","journal-title":"Lancet (london, England)"},{"key":"9984_CR19","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1097\/ADM.0000000000000308","volume":"11","author":"SL Klaman","year":"2017","unstructured":"Klaman, S. L., Isaacs, K., Leopold, A., Perpich, J., Hayashi, S., Vender, J., Campopiano, M., & Jones, H. E. (2017). Treating women who are pregnant and parenting for opioid use disorder and the concurrent care of their infants and children: Literature review to support national guidance. Journal of Addiction Medicine, 11, 178\u2013190.","journal-title":"Journal of Addiction Medicine"},{"key":"9984_CR20","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1097\/AOG.0000000000001446","volume":"128","author":"EE Krans","year":"2016","unstructured":"Krans, E. E., & Patrick, S. W. (2016). Opioid use disorder in pregnancy: Health policy and practice in the midst of an epidemic. Obstetrics and Gynecology, 128, 4\u201310.","journal-title":"Obstetrics and Gynecology"},{"key":"9984_CR21","volume-title":"Behavioral activation for depression: A clinician\u2019s guide","author":"CR Martell","year":"2010","unstructured":"Martell, C. R., Dimidjian, S., & Herman-Dunn, R. (2010). Behavioral activation for depression: A clinician\u2019s guide. New York: The Guilford Press."},{"issue":"1","key":"9984_CR22","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s13011-018-0173-2","volume":"13","author":"C Mart\u00ednez-Vispo","year":"2018","unstructured":"Mart\u00ednez-Vispo, C., Mart\u00ednez, \u00da., L\u00f3pez-Dur\u00e1n, A., Fern\u00e1ndez Del R\u00edo, E., & Beco\u00f1a, E. (2018). Effects of behavioural activation on substance use and depression: A systematic review. Substance Abuse Treatment, Prevention, and Policy, 13(1), 36.","journal-title":"Substance Abuse Treatment, Prevention, and Policy"},{"key":"9984_CR23","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.cpr.2018.06.004","volume":"66","author":"YI Nillni","year":"2018","unstructured":"Nillni, Y. I., Mehralizade, A., Mayer, L., & Milanovic, S. (2018). Treatment of depression, anxiety, and trauma-related disorders during the perinatal period: A systematic review. Clinical Psychology Review, 66, 136\u2013148.","journal-title":"Clinical Psychology Review"},{"key":"9984_CR24","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1080\/09540261.2021.1898351","volume":"33","author":"ER Raffi","year":"2021","unstructured":"Raffi, E. R., Gray, J., Conteh, N., Kane, M., Cohen, L. S., & Schiff, D. M. (2021). Low barrier perinatal psychiatric care for patients with substance use disorder: Meeting patients across the perinatal continuum where they are. International Review of Psychiatry (abingdon, England), 33, 543\u2013552.","journal-title":"International Review of Psychiatry (abingdon, England)"},{"key":"9984_CR25","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.genhosppsych.2004.02.006","volume":"26","author":"E Robertson","year":"2004","unstructured":"Robertson, E., Grace, S., Wallington, T., & Stewart, D. E. (2004). Antenatal risk factors for postpartum depression: A synthesis of recent literature. General Hospital Psychiatry, 26, 289\u2013295.","journal-title":"General Hospital Psychiatry"},{"key":"9984_CR26","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1097\/AOG.0000000000003279","volume":"133","author":"MC Smid","year":"2019","unstructured":"Smid, M. C., Stone, N. M., Baksh, L., Debbink, M. P., Einerson, B. D., Varner, M. W., Gordon, A. J., & Clark, E. (2019). Pregnancy-associated death in Utah: Contribution of drug-induced deaths. Obstetrics and Gynecology, 133, 1131\u20131140.","journal-title":"Obstetrics and Gynecology"},{"key":"9984_CR27","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/906723","volume":"2014","author":"VE Whiteman","year":"2014","unstructured":"Whiteman, V. E., Salemi, J. L., Mogos, M. F., Cain, M. A., Aliyu, M. H., & Salihu, H. M. (2014). Maternal opioid drug use during pregnancy and its impact on perinatal morbidity, mortality, and the costs of medical care in the United States. Journal of Pregnancy, 2014, 906723.","journal-title":"Journal of Pregnancy"}],"container-title":["Journal of Clinical Psychology in Medical Settings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10880-023-09984-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10880-023-09984-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10880-023-09984-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,17]],"date-time":"2025-03-17T09:42:18Z","timestamp":1742204538000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10880-023-09984-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,16]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["9984"],"URL":"https:\/\/doi.org\/10.1007\/s10880-023-09984-y","relation":{},"ISSN":["1068-9583","1573-3572"],"issn-type":[{"value":"1068-9583","type":"print"},{"value":"1573-3572","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,16]]},"assertion":[{"value":"29 October 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 May 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no competing interests to declare that are relevant to the content of this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This retrospective chart review study involving human participants was in accordance with the ethical standards of the institutional and national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. The Human Investigation Committee (IRB) of The Ohio State University approved this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}